These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25228365)

  • 61. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.
    Hsu F; Nichol A; Toriumi T; De Caluwe A
    Acta Oncol; 2017 Sep; 56(9):1175-1180. PubMed ID: 28521651
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South.
    Kelly D; Mc Sorley L; O'Shea E; Mc Carthy E; Bowe S; Brady C; Sui J; Dawod MA; O'Brien O; Graham D; McCarthy J; Burke L; Power D; O'Reilly S; Bambury RM; Mahony DO
    Ir J Med Sci; 2017 Nov; 186(4):855-857. PubMed ID: 28185061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.
    Guan J; Chen M; Xiao N; Li L; Zhang Y; Li Q; Yang M; Liu L; Chen L
    Med Oncol; 2016 Jan; 33(1):1. PubMed ID: 26589606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer.
    Malapelle U; Vatrano S; Russo S; Bellevicine C; de Luca C; Sgariglia R; Rocco D; de Pietro L; Riccardi F; Gobbini E; Righi L; Troncone G
    J Clin Pathol; 2015 Sep; 68(9):739-41. PubMed ID: 26047622
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
    Tan L; Alexander M; Officer A; MacManus M; Mileshkin L; Jennens R; Herath D; de Boer R; Fox SB; Ball D; Solomon B
    Intern Med J; 2018 Jan; 48(1):37-44. PubMed ID: 28544061
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical outcome of node-negative oligometastatic non-small cell lung cancer.
    Sakai K; Takeda M; Hayashi H; Tanaka K; Okuda T; Kato A; Nishimura Y; Mitsudomi T; Koyama A; Nakagawa K
    Thorac Cancer; 2016 Nov; 7(6):670-675. PubMed ID: 27755813
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status.
    Aye PS; McKeage MJ; Tin Tin S; Khwaounjoo P; Elwood JM
    Cancer Epidemiol; 2020 Dec; 69():101847. PubMed ID: 33126040
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer].
    Bai H; Zhao J; Wang SH; An TT; Wang X; Wu MN; Duan JC; Yang L; Guo QZ; Liu NH; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):891-6. PubMed ID: 19134404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.
    Aye PS; McKeage MJ; Tin Tin S; Khwaounjoo P; Elwood JM
    PLoS One; 2021; 16(5):e0251357. PubMed ID: 33961689
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.
    McKeage M; Elwood M; Tin Tin S; Khwaounjoo P; Aye P; Li A; Sheath K; Shepherd P; Laking G; Kingston N; Lewis C; Love D
    Target Oncol; 2017 Oct; 12(5):663-675. PubMed ID: 28699084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The impact of epidermal growth factor receptor mutations on patterns of disease recurrence after chemoradiotherapy for locally advanced non-small cell lung cancer: a literature review and pooled analysis.
    Ochiai S; Nomoto Y; Watanabe Y; Yamashita Y; Toyomasu Y; Kawamura T; Takada A; Noriko ; Sakuma H
    J Radiat Res; 2016 Sep; 57(5):449-459. PubMed ID: 27534790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
    Wu Y; Liu H; Shi X; Song Y
    Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung.
    Shin DY; Lee DH; Kim CH; Koh JS; Lee JC; Baek HJ; Kim SW; Choi CM; Na II
    J Cancer Res Ther; 2016; 12(1):318-22. PubMed ID: 27072258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.
    Liu TC; Hsieh MJ; Wu WJ; Chou YE; Chiang WL; Yang SF; Su SC; Tsao TC
    Int J Med Sci; 2016; 13(12):929-935. PubMed ID: 27994498
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of underlying lung disease in smokers with epidermal growth factor receptor-mutant lung cancer.
    Sekine A; Tamura K; Satoh H; Tanaka T; Tsunoda Y; Tanaka T; Takoi H; Lin SY; Yatagai Y; Hashizume T; Hayasihara K; Saito T
    Oncol Rep; 2013 May; 29(5):2005-10. PubMed ID: 23467672
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery].
    Liu Y; Zhu JQ; Zhang LM; Zhang TM; Zhang ZF; Wang CL
    Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1082-6. PubMed ID: 23336484
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer].
    Luo D; Ma J; Zhang J; Zhao Y
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):415-420. PubMed ID: 28641700
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study.
    Jacobs JM; Traeger L; Eusebio J; Simon NM; Sequist LV; Greer JA; Temel JS; Pirl WF
    J Psychosom Res; 2017 Aug; 99():28-33. PubMed ID: 28712427
    [TBL] [Abstract][Full Text] [Related]  

  • 79. EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.
    Berg J; Fjellbirkeland L; Suhrke P; Jebsen P; Lund-Iversen M; Kleinberg L; Helgeland L; Brustugun OT; Helland Å
    Acta Oncol; 2016; 55(2):149-55. PubMed ID: 26313507
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Value of detecting epidermal growth factor receptor mutations in non-small cell lung cancer tissue by TaqMan-amplification refractory mutation system].
    Dou YL; Qi XL; Xin L; Chen D; Zhang HQ; Cui QC
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):768-71. PubMed ID: 23755816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.